Literature DB >> 3950057

The effect of size and shape of tablets on their esophageal transit.

K S Channer, J P Virjee.   

Abstract

The esophageal transit times of small- and medium-sized barium sulfate tablets were measured using x-ray fluoroscopy in 50 patients after swallowing while in both erect and supine positions with a 15-mL drink, and the esophageal transit times of large round and oval barium sulfate tablets were similarly measured in 25 patients. When tablets were swallowed by subjects who were standing, no difference was found between the transit times of small and medium tablets, but large oval tablets had significantly shorter times than did large round tablets (P less than .04). The transit times of both small and medium tablets were significantly shorter than those of oval (P less than .05) and large round tablets (P less than .02). Retention of large oval and round tablets in the esophagus occurred in 20% of patients after swallowing while in the standing position. No medium-sized tablet was retained, but in 4% of patients, a small tablet remained in the esophagus. Tablets that were retained in the esophagus remained there for five minutes, when they were washed down by a further drink. When tablets were swallowed in the lying position, no significant differences in transit times were found between any of the four tablets. Retention of tablets within the esophagus occurred in over 60% of patients with all four tablets after ingestion while in the supine position. Tablets stuck mainly in the lower esophagus above the lower esophageal sphincter, but after swallowing in the standing position, a significant proportion (33% [P less than .01]) stuck in the upper esophagus.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3950057     DOI: 10.1002/j.1552-4604.1986.tb02922.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  13 in total

1.  Dynamics of capsule swallowing by healthy young men and capsule transit time from the mouth to the stomach.

Authors:  Hiromi Chisaka; Yasuyuki Matsushima; Futoshi Wada; Satoru Saeki; Kenji Hachisuka
Journal:  Dysphagia       Date:  2006-10       Impact factor: 3.438

Review 2.  Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management.

Authors:  D Jaspersen
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

3.  Patients' evaluation of shape, size and colour of solid dosage forms.

Authors:  A B Overgaard; J Højsted; R Hansen; J Møller-Sonnergaard; L L Christrup
Journal:  Pharm World Sci       Date:  2001-10

4.  Impaired oesophageal transit of capsule versus tablet formulations in the elderly.

Authors:  A C Perkins; C G Wilson; P E Blackshaw; R M Vincent; R J Dansereau; K D Juhlin; P J Bekker; R C Spiller
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

5.  Preparation of High-Drug-Loaded Clarithromycin Gastric-Floating Sustained-Release Tablets Using 3D Printing.

Authors:  Peihong Chen; Haosen Luo; Siyu Huang; Jinling Liu; Minmei Lin; Fan Yang; Junfeng Ban; Zeju Huang; Zhufen Lu; Qingchun Xie; YanZhong Chen
Journal:  AAPS PharmSciTech       Date:  2021-04-11       Impact factor: 3.246

6.  Pharmacokinetic evaluation of rofecoxib : comparison of tablet and suspension formulations.

Authors:  Jules I Schwartz; Patrick J Larson; Arturo G Porras; Kala-Jyoti Viswanathan-Aiyer; Nancy G B Agrawal; Kenneth C Lasseter; Ralph S Mazenko; Sheila A Merschman; Barry J Gertz
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

7.  Dosage form preference consultation study in children and young adults: paving the way for patient-centred and patient-informed dosage form development.

Authors:  Hamad Alyami; Eman Dahmash; Fahad Alyami; Dania Dahmash; Chi Huynh; David Terry; Afzal R Mohammed
Journal:  Eur J Hosp Pharm       Date:  2016-09-02

Review 8.  Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations.

Authors:  Fang Liu; Sejal Ranmal; Hannah K Batchelor; Mine Orlu-Gul; Terry B Ernest; Iwan W Thomas; Talia Flanagan; Catherine Tuleu
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

9.  Efficacy of switching to dolutegravir plus rilpivirine, the small-tablet regimen, in patients with dysphagia: two case reports.

Authors:  Takefumi Suzuki; Nobuko Hara; Morichika Osa; Kazuhisa Misawa; Kazuo Imai; Yuji Fujikura; Takuya Maeda; Wataru Sonehara; Akihiko Kawana
Journal:  J Pharm Health Care Sci       Date:  2017-09-19

10.  Adherence, satisfaction, and experience with metformin 500 mg prolonged release formulation in Indian patients with type 2 diabetes mellitus: a postmarketing observational study.

Authors:  K M Prasanna Kumar; Manoj Chawla; Ami Sanghvi; Nadiminty G Sastry; Chaitanya Kotla; Sanjeev Phatak; Sanjay Choudhari
Journal:  Int J Gen Med       Date:  2019-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.